文献速递妇科肿瘤

子宫内膜癌中肿瘤浸润NK细胞的预后获益依赖于HLA-E过表达

The prognostic benefit of tumour-infiltrating Natural Killer cells in endometrial cancer is dependent on concurrent overexpression of Human Leucocyte Antigen-E in the tumour microenvironment.
PubMed 文献 · Eur J Cancer · 2017-10-20

该研究利用子宫内膜癌组织芯片进行免疫组化染色,分析HLA-E表达与肿瘤浸润NK细胞及细胞毒性T细胞对生存的影响。多因素分析显示,HLA-E上调时NK细胞预测生存的HR为0.28,而HLA-E正常时NK细胞与更差预后相关(HR 13.43)。T细胞的预后获益未受HLA-E表达调节。

要点

  • HLA-E上调在单因素分析中与改善的无病生存和疾病特异性生存相关。
  • 多因素分析中,HLA-E上调时NK细胞预测生存的HR为0.28(95%CI 0.09-0.91)。
  • HLA-E表达正常时,NK细胞与更差预后相关(HR 13.43,95%CI 1.70-106.14)。

核心结论

  • 在子宫内膜癌中,NK细胞而非T细胞的预后获益受HLA-E表达影响,并据此提出解释观察结果的模型。

研究设计与样本

  • 使用子宫内膜肿瘤组织芯片(TMA)进行感兴趣参数的免疫组化染色。
  • 采用log rank检验和Cox回归分析临床、病理及免疫参数对生存的联合影响。

主要发现

  • 单因素分析中,HLA-E上调与改善的无病生存相关(HR 0.58,95%CI 0.37-0.89)。
  • 单因素分析中,HLA-E上调与改善的疾病特异性生存相关(HR 0.42,95%CI 0.25-0.73)。
  • 多因素分析中,HLA-E表达上调时NK细胞预测生存的HR为0.28(95%CI 0.09-0.91)。
  • HLA-E表达正常时,NK细胞与更差预后相关(HR 13.43,95%CI 1.70-106.14)。
  • T细胞的预后获益未受HLA-E表达调节。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Human Leucocyte Antigen- E (HLA-E) has been reported as both a positive and negative prognostic marker in cancer. This apparent discrepancy may be due to opposing actions of HLA-E on tumour-infiltrating immune cells. Therefore, we evaluated HLA-E expression and survival in relation to the presence of intratumoural natural killer (NK) cells and cytotoxic T cells (CTLs). METHODS: Tissue microarrays (TMAs) of endometrial tumours were used for immunohistochemical staining of parameters of interest. The combined impact of clinical, pathological and immune parameters on survival was analysed using log rank testing and Cox regression analyses. RESULTS: Upregulation of HLA-E was associated with an improved disease-free and disease-specific survival in univariate analysis (HR 0.58 95% CI 0.37-0.89; HR 0.42 95% CI 0.25-0.73, respectively). In multivariate analysis, the presence of NK cells predicts survival with a hazard ratio (HR) 0.28 (95% confidence interval (CI) 0.09-0.91) when HLA-E expression is upregulated; but it is associated with a worse prognosis when HLA-E expression is normal (HR 13.43, 95% CI 1.70-106.14). By contrast, the prognostic benefit of T cells was not modulated by HLA-E expression. CONCLUSIONS: Taken together, we demonstrate that the prognostic benefit of NK cells, but not T-cells, is influenced by HLA-E expression in endometrial cancer (EC) and propose a model to explain our observations.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Versluis MAC, Marchal S, Plat A, et al. The prognostic benefit of tumour-infiltrating Natural Killer cells in endometrial cancer is dependent on concurrent overexpression of Human Leucocyte Antigen-E in the tumour microenvironment. Eur J Cancer. 2017. PMID: 29059634. doi:10.1016/j.ejca.2017.09.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。